LISATA THERAPEUTICS, INC.: capex
| Value | {"amount": 1099460, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} |
|---|---|
| Period | 2016-01-01 – 2016-12-31 |
| Status | current |
| Entity | LISATA THERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T07:30:03.792427+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/0f5a7a37-7eec-4e4e-8977-477a2bb10cbb
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0000320017-18-000021 · Open the official SEC filing →Retrieved: 2026-08-19T07:30:03.792427+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000320017/capex/2016-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/0f5a7a37-7eec-4e4e-8977-477a2bb10cbb
History
- supersedes {"amount": 2849296, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} (evidence 0000320017-17-000008)